• Subscribe
  • Magazine
  • Videos
  • Advertise
  • About Us
  • Smart Water Summit
  • Wastewater Summit
    • Recent Quotes
    My Watchlist
    Indicators
    WaterWorld Market Index
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    Krystal Biotech, Inc. - Common Stock (NQ:KRYS)

    195.96 UNCHANGED
    Streaming Delayed Price Updated: 4:00 PM EDT, Oct 20, 2025 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    All News about Krystal Biotech, Inc. - Common Stock

    < Previous 1 2 3 4 5 6 Next >
    Expert Outlook: Krystal Biotech Through The Eyes Of 9 Analysts
     
    Via Benzinga
    $100 Invested In Krystal Biotech 5 Years Ago Would Be Worth This Much Today
     
    Via Benzinga
    Insider Confidence Shines: Krystal Biotech and Growth Stocks with Strong Management Stakes Navigate Volatile Markets
    The U.S. stock market is currently a landscape of contrasting forces, with robust bank earnings providing a bedrock of stability against the backdrop of persistent trade tensions with China and... 
    Via MarketMinute
    Topics Artificial Intelligence World Trade
    What's Driving the Market Sentiment Around Krystal Biotech Inc?
     
    Via Benzinga
    Earnings Scheduled For August 4, 2025
     
    Via Benzinga
    Earnings Outlook For Krystal Biotech
     
    Via Benzinga
    Analyst Expectations For Krystal Biotech's Future
     
    Via Benzinga
    Peering Into Krystal Biotech's Recent Short Interest
     
    Via Benzinga
    6 Stocks Goldman Sachs Says Are Poised For Potential Acquisition In Next 12 Months — Including A Huge 200% Winner
    Goldman Sachs has highlighted six stocks that have a high probability of being acquisition targets in the next year. 
    Via Benzinga
    If You Invested $1000 In Krystal Biotech Stock 5 Years Ago, You Would Have This Much Today
    Krystal Biotech (NASDAQ: KRYS) has outperformed the market over the past 5 years by 16.54% on an annualized basis producing an average annual return of 31.18%. Currently, Krystal Biotech has a market... 
    Via Benzinga
    Here's How Much $100 Invested In Krystal Biotech 5 Years Ago Would Be Worth Today
     
    Via Benzinga
    FDA Expands Krystal Biotech Vyjuvek's Label Allowing Newborns Access To Gene Therapy For Blistering Skin
    The FDA approved Krystal Biotech's Vyjuvek label update, expanding treatment to newborns and offering flexible wound care based on real-world patient data. 
    Via Benzinga
    What Does the Market Think About Krystal Biotech?
     
    Via Benzinga
    If You Invested $100 In This Stock 5 Years Ago, You Would Have This Much Today
     
    Via Benzinga
    A Glimpse Into The Expert Outlook On Krystal Biotech Through 10 Analysts
     
    Via Benzinga
    If You Invested $1000 In This Stock 5 Years Ago, You Would Have This Much Today
     
    Via Benzinga
    What 8 Analyst Ratings Have To Say About Krystal Biotech
     
    Via Benzinga
    Crude Oil Falls 1.5%; ON Semiconductor Shares Plunge After Q2 Results
     
    Via Benzinga
    Krystal (KRYS) Q2 Profit Jumps 143%
    Via The Motley Fool
    KRYSTAL BIOTECH INC (NASDAQ:KRYS) Q2 2025 Earnings Beat Estimates as VYJUVEK Drives Strong Revenue Growth
    Krystal Biotech (KRYS) Q2 2025 earnings beat estimates with $96M revenue and $1.29 EPS, driven by VYJUVEK success. Shares rose 4% pre-market. 
    Via Chartmill
    Topics Earnings
    Here's How Much $100 Invested In Krystal Biotech 5 Years Ago Would Be Worth Today
     
    Via Benzinga
    $1000 Invested In This Stock 5 Years Ago Would Be Worth This Much Today
     
    Via Benzinga
    Here's How Much You Would Have Made Owning Krystal Biotech Stock In The Last 5 Years
     
    Via Benzinga
    10 Under-the-Radar Healthcare Stocks With Incredible Growth Potential
    Via The Motley Fool
    Topics Artificial Intelligence
    Demystifying Krystal Biotech: Insights From 7 Analyst Reviews
     
    Via Benzinga
    $100 Invested In This Stock 5 Years Ago Would Be Worth This Much Today
     
    Via Benzinga
    $100 Invested In This Stock 5 Years Ago Would Be Worth This Much Today
    Via Benzinga
    The Analyst Verdict: Krystal Biotech In The Eyes Of 12 Experts
     
    Via Benzinga
    Pharma Fire Sale: 3 Stocks the RSI Says You Shouldn’t Ignore
    These 3 pharma stocks have oversold RSIs and solid analyst support, setting up potential bounce-back trades through this week and next 
    Via MarketBeat
    Topics Earnings
    If You Invested $1000 In This Stock 5 Years Ago, You Would Have This Much Today
     
    Via Benzinga
    < Previous 1 2 3 4 5 6 Next >
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.